133 related articles for article (PubMed ID: 11215258)
21. [Availability of antidotes in Denmark].
Jacobsen P; Kristensen TR; Jensen K
Ugeskr Laeger; 2004 Nov; 166(47):4257-60. PubMed ID: 15587358
[No Abstract] [Full Text] [Related]
22. Toxicology today: what you need to know now.
Lam SW; Engebretsen KM; Bauer SR
J Pharm Pract; 2011 Apr; 24(2):174-88. PubMed ID: 21712212
[TBL] [Abstract][Full Text] [Related]
23. Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.
Manoguerra AS; Erdman AR; Woolf AD; Chyka PA; Caravati EM; Scharman EJ; Booze LL; Christianson G; Nelson LS; Cobaugh DJ; Troutman WG;
Clin Toxicol (Phila); 2008 Aug; 46(7):661-76. PubMed ID: 18608263
[TBL] [Abstract][Full Text] [Related]
24. Nano-antidotes for drug overdose and poisoning.
Forster V; Leroux JC
Sci Transl Med; 2015 Jun; 7(290):290ps14. PubMed ID: 26041703
[TBL] [Abstract][Full Text] [Related]
25. [The importance and value of the toxicological and biochemical results in the management of the poisoned patient].
Groszek B
Przegl Lek; 2007; 64(4-5):191-3. PubMed ID: 17724863
[TBL] [Abstract][Full Text] [Related]
26. [Acute poisoning. 3: Emergency measures in the clinic].
Horn J
Fortschr Med; 1995 Apr; 113(11):161-3. PubMed ID: 7768478
[No Abstract] [Full Text] [Related]
27. Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning.
Johnson S; Peter JV; Thomas K; Jeyaseelan L; Cherian AM
J Assoc Physicians India; 1996 Aug; 44(8):529-31. PubMed ID: 9251423
[TBL] [Abstract][Full Text] [Related]
28. Clinical and institutional aspects of antidote therapy in Russia.
Ostapenko YN; Luzhnikov EA; Nechiporenko SP; Petrov AN
Przegl Lek; 2001; 58(4):290-2. PubMed ID: 11450355
[TBL] [Abstract][Full Text] [Related]
29. Drug-specific Fab therapy in drug overdose.
Hursting MJ; Raisys VA; Opheim KE
Arch Pathol Lab Med; 1987 Aug; 111(8):693-7. PubMed ID: 3632280
[TBL] [Abstract][Full Text] [Related]
30. [Treatment with activated charcoal after poisoning is not without benefits].
Dalhoff K
Ugeskr Laeger; 2008 Apr; 170(15):1260; author reply 1260. PubMed ID: 18472463
[No Abstract] [Full Text] [Related]
31. [Digitalis poisoning treated with a specific antidote].
Rykke EO; Bredesen JE; Stokland O; Jacobsen D
Tidsskr Nor Laegeforen; 1998 Jan; 118(3):408-10. PubMed ID: 9499730
[TBL] [Abstract][Full Text] [Related]
32. Antidote use in the critically ill poisoned patient.
Betten DP; Vohra RB; Cook MD; Matteucci MJ; Clark RF
J Intensive Care Med; 2006; 21(5):255-77. PubMed ID: 16946442
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic, activated charcoal to pediatric poisoning patients].
Christophersen AB; Angelo HR; Christensen HR
Ugeskr Laeger; 2001 Jan; 163(4):467. PubMed ID: 11218790
[No Abstract] [Full Text] [Related]
34. [Possible combinations of antidotal therapy in rats following intoxication with phosphoric acid esters (author's transl)].
Brüner H; Gandawidjaja L; Hettwer H; Oldiges H
Arzneimittelforschung; 1977; 27(10):1983-8. PubMed ID: 336055
[TBL] [Abstract][Full Text] [Related]
35. Management of the drug overdose patient. Part II. Specific antidotes.
Bianchine JR; Couri D
Ohio State Med J; 1977 Jul; 73(7):451-2. PubMed ID: 882237
[No Abstract] [Full Text] [Related]
36. [Experimental and clinical findings on treatment of cardiac-glucoside intoxication].
Erdmann E; Krawietz W; Poppert D
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1678-81. PubMed ID: 1030078
[No Abstract] [Full Text] [Related]
37. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study.
Ghannoum M; Lavergne V; Yue CS; Ayoub P; Perreault MM; Roy L
Clin Toxicol (Phila); 2010 Jan; 48(1):34-41. PubMed ID: 19842945
[TBL] [Abstract][Full Text] [Related]
38. Off-label and unlicensed use of antidotes in paediatric patients.
Lifshitz M; Gavrilov V; Gorodischer R
Eur J Clin Pharmacol; 2001; 56(11):839-41. PubMed ID: 11294375
[TBL] [Abstract][Full Text] [Related]
39. The poison center as a reservoir for antidotes for veterinary poisoning emergencies.
Krenzelok EP; Drake T; Dean BS
Vet Hum Toxicol; 1992 Apr; 34(2):168-9. PubMed ID: 1509683
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and management of cyanide poisoning.
Holland MA; Kozlowski LM
Clin Pharm; 1986 Sep; 5(9):737-41. PubMed ID: 3530615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
